Andy led a programme of research in developmental genetics at the UKRI’s MRC Harwell Institute for 25 years. He now focuses on matters of governance and regulation. He was a board member of the HFEA for almost 10 years and chaired two expert panels that considered the safety and efficacy of mitochondrial donation. He was a member of the Nuffield Council on Bioethics (NCoB) and in 2016 chaired its working group that considered the ethics of genome editing. He was also a member of NCoB’s recent SCBEM working group. In 2019-2020, he was a member of the National Academies International Commission that considered possible clinical uses of heritable human genome editing.
Since 2020, he has been a member of the Regulatory Horizons Council, an expert committee that advises the UK Government on the regulation of emerging technologies in diverse sectors. He also works with a number of UK regulators.